Talus Bioscience logo

Talus Bioscience

talus.bio

Talus Bioscience develops AI models and native-cell proteomics technology for drug discovery. Its Ptarmigan-1 model predicts how small molecules engage proteins without requiring a 3D structure, while MARMOT measures protein interactions and changes in living human cells, enabling researchers to investigate hard-to-drug targets such as disordered proteins and transcription factors.

Facts

HQ
Seattle, Washington
Sectors
Biotechnology Research
Founded
2020
Type
Corporation Seattle business license
Employees
24
Registered name
Talus Bioscience Inc Seattle business license
Stage
Seed
Members see funding amounts.
.
Founders
Alex Federation, Lindsay Pino

Is this your organization? Claim it

Talus Bioscience launches structure-free AI model to target disordered ‘undruggable’ proteins in native cellular context

Talus Bioscience (Talus Bio) is developing a structure-free AI model to study and drug intrinsically disordered proteins in their native cellular context, aiming to tackle historically 'undruggable' targets; the company was co-founded by CEO Alex Federation, PhD, and CTO Lindsay Pino, PhD, building on proteomics and AI-driven screening approaches.

See all 13 stories, episodes and videos about Talus Bioscience.

People

  • Alex Federation
    Alex Federation Executive Officer, Director, Promoter, Chief Executive Officer & Co-Founder
  • Lindsay Pino Executive Officer, Director, Chief Technology Officer & Co-Founder
  • Michelle Briscoe Executive, Executive Officer, Chief Operating Officer & Chief Financial Officer

Online